Microbiome product manufacturing

Emma Allen-Vercoe has established a world leading capability to grow microbes in a controlled environment. The intent of our newly established Biotech company – NuBiyota – will be to translate this exciting capability into a therapeutic product. The project we are proposing will leverage Kathleen’s expertise and experience in professor Allen-Vercoe’s lab, combined with the company’s GMP expertise to create a clinical/commercial grade Microbiome therapeutic product. The initial effort will enable NuBiyota to begin a multi-center randomized control clinical trial to demonstrate the clinical efficacy and safety of our Microbiome therapy for recurrent Clostridium difficile infections.

Faculty Supervisor:

Emma Allen-Vercoe

Student:

Partner:

NuBiyota

Discipline:

Life Sciences

Sector:

Biotechnology

University:

University of Guelph

Program: